Document Page: First | Prev | Next | All | Image | This Release | Search
File: 120596_aacym_02.txt-- Wearability: --- Some decrease in effectiveness of TSP after washing protected area with a volume of water 500 times that of the volume of TSP applied and allowing to dry 1 hour prior to HD exposure. (Lesion area reduction decreased from 89% to 74% for a 1 hour exposure and from 83 to 51% for a 2 hour exposure compared to unprotected control) (Atch 3) --- In human testing under environmental conditions equivalent to the Saudi Arabian environment, (111 degrees F, 20% relative humidity, 5 mph wind) Multi Shield on the human forearm provided up to 70% protection against liquid or vapor exposures for a 0.2 mm layer and 40% protection for a 0.1 mm layer following 1 hour simulant challenges as long as 8 hours after Multi Shield application. (Atch 4) -- Operational Considerations: --- No compromise of chemical mask seal in 22 volunteers undergoing a battery of tests and exercises in a simulant chamber after applying Multi Shield to the face. -- - No compromise of effectiveness of the M258A1 or M291 decontamination kits when used in the presence of Multi Shield. (Atch 5) --- Some limited potential interference with chemical agent detectors: ---- False positive response for G agents in the M8A1, XM88 and CAM detectors, but only on the most sensitive scale and when the elapsed time for sensing was considerably longer than that normally required to detect agents. ---- Positive G response on M8 paper approximately 30 minutes after contact with Multi Shield. -- Safety and Toxicity Testing: --- No evidence of irritancy following dermal patch testing in shaved rabbits. --- No apparent toxicity following ingestion of high doses (5 gm/km) in rodents. --- Minor discomfort and possible minor eye irritation after eye exposure in manufacturer's testing; in Army tests, no indication of irritation following placement of Multi Shield in rabbit eyes. --- In use "over the counter" in us since 1985 with no adverse affects reported. -- FDA Status: DoD submission of Investigational New Drug (IND) application for use of Multi Shield for protection against mustard injury scheduled 4 Oct 90; Army protocol review scheduled 10 Oct; quick action expected due to urgent need in support of Operation DESERT SHIELD. -- Utilization Estimates: Approximately 1 oz per application (based on 1300 sq cm coverage for neck, wrists, and ankles with a 0.1 to 0.2mm layer; specific gravity of 1 g/cc and estimating 10% wastage). Under conditions of MOPP 1, 2 to 3 applications per day would probably be needed but
Document Page: First | Prev | Next | All | Image | This Release | Search